Changzhou Qianhong Biopharma Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 18.70%

Changzhou Qianhong Biopharma Co Ltd (002550) has an Asset Resilience Ratio of 18.70% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥604.36 Million

≈ $88.44 Million USD Cash + Short-term Investments

Total Assets

CN¥3.23 Billion

≈ $472.92 Million USD All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (2007–2025)

This chart shows how Changzhou Qianhong Biopharma Co Ltd's Asset Resilience Ratio has changed over time. Check Changzhou Qianhong Biopharma Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Changzhou Qianhong Biopharma Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 002550 market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥604.36 Million	18.7%
Total Liquid Assets	CN¥604.36 Million	18.70%

Asset Resilience Insights

Good Liquidity Position: Changzhou Qianhong Biopharma Co Ltd maintains a healthy 18.70% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Changzhou Qianhong Biopharma Co Ltd Industry Peers by Asset Resilience Ratio

Compare Changzhou Qianhong Biopharma Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Company Limited F:TKDA	Drug Manufacturers - Specialty & Generic	0.69%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Beijing Sun Novo Pharmaceutical Research Co Ltd SHG:688621	Drug Manufacturers - Specialty & Generic	2.04%
Guizhou Xinbang Pharmaceutical Co Ltd SHE:002390	Drug Manufacturers - Specialty & Generic	0.01%
Guangdong Lifestrong Pharmacy Co. Ltd. SHE:301111	Drug Manufacturers - Specialty & Generic	7.85%
Jw Pharmac KO:001060	Drug Manufacturers - Specialty & Generic	3.65%
Kamada TA:KMDA	Drug Manufacturers - Specialty & Generic	0.00%
Samjin Pharm KO:005500	Drug Manufacturers - Specialty & Generic	0.25%

Annual Asset Resilience Ratio for Changzhou Qianhong Biopharma Co Ltd (2007–2025)

The table below shows the annual Asset Resilience Ratio data for Changzhou Qianhong Biopharma Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	19.24%	CN¥594.02 Million ≈ $86.92 Million	CN¥3.09 Billion ≈ $451.70 Million	+9.57pp
2024-12-31	9.67%	CN¥273.83 Million ≈ $40.07 Million	CN¥2.83 Billion ≈ $414.18 Million	+4.72pp
2023-12-31	4.95%	CN¥136.93 Million ≈ $20.04 Million	CN¥2.77 Billion ≈ $404.76 Million	+2.55pp
2022-12-31	2.40%	CN¥67.48 Million ≈ $9.87 Million	CN¥2.81 Billion ≈ $410.60 Million	-0.32pp
2021-12-31	2.72%	CN¥68.23 Million ≈ $9.98 Million	CN¥2.51 Billion ≈ $367.06 Million	-6.84pp
2020-12-31	9.56%	CN¥234.28 Million ≈ $34.28 Million	CN¥2.45 Billion ≈ $358.77 Million	-13.04pp
2019-12-31	22.59%	CN¥662.98 Million ≈ $97.01 Million	CN¥2.93 Billion ≈ $429.38 Million	-19.09pp
2018-12-31	41.69%	CN¥1.32 Billion ≈ $193.89 Million	CN¥3.18 Billion ≈ $465.09 Million	-10.30pp
2017-12-31	51.99%	CN¥1.58 Billion ≈ $231.61 Million	CN¥3.04 Billion ≈ $445.48 Million	--
2016-12-31	0.00%	CN¥0.00 ≈ $0.00	CN¥3.03 Billion ≈ $443.95 Million	--
2015-12-31	0.36%	CN¥10.25 Million ≈ $1.50 Million	CN¥2.83 Billion ≈ $414.58 Million	-0.08pp
2014-12-31	0.44%	CN¥10.23 Million ≈ $1.50 Million	CN¥2.31 Billion ≈ $338.13 Million	+0.43pp
2013-12-31	0.02%	CN¥362.70K ≈ $53.07K	CN¥2.07 Billion ≈ $302.36 Million	0.00pp
2012-12-31	0.02%	CN¥338.65K ≈ $49.56K	CN¥1.93 Billion ≈ $282.04 Million	0.00pp
2011-12-31	0.02%	CN¥369.85K ≈ $54.12K	CN¥1.85 Billion ≈ $271.18 Million	-0.06pp
2010-12-31	0.08%	CN¥431.60K ≈ $63.16K	CN¥548.53 Million ≈ $80.27 Million	-0.01pp
2009-12-31	0.09%	CN¥464.10K ≈ $67.91K	CN¥533.87 Million ≈ $78.12 Million	0.00pp
2008-12-31	0.09%	CN¥353.60K ≈ $51.74K	CN¥391.74 Million ≈ $57.32 Million	-0.15pp
2007-12-31	0.24%	CN¥683.80K ≈ $100.06K	CN¥288.56 Million ≈ $42.23 Million	--

pp = percentage points

About Changzhou Qianhong Biopharma Co Ltd

SHE:002550 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.30 Billion

CN¥8.91 Billion CNY

Market Cap Rank

#7682 Global

#1694 in China

Share Price

CN¥6.96

Change (1 day)

+2.50%

52-Week Range

CN¥5.78 - CN¥11.89

All Time High

CN¥12.27